New Issue: Vivus prices $33.6 million direct placement of stock

By Sheri Kasprzak

New York, Nov. 17 - Vivus, Inc. negotiated a direct placement of its stock for $33.6 million.

The company plans to sell 9.6 million shares at $3.50 each, a 2.77% discount to the company's $3.60 closing stock price on Wednesday.

Vivus, based in Mountain View, Calif., is a pharmaceutical company focused on treatments for obesity and sexual dysfunction.

Issuer:	Vivus, Inc.
Issue:	Stock
Amount:	$33.6 million
Shares:	9.6 million
Price:	$3.50
Warrants:	No
Pricing date:	Nov. 17
Stock symbol:	Nasdaq: VVUS
Stock price:	$3.70 at close Nov. 17

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.